LF LFVN LifeVantage Corporation Loading... : Investor Sentiment and Bull/Bear Views

The author argues LFVN is set up for a short squeeze because short interest is +40%, the borrow rate is 280%, and zero shares are available to short, while volume has expanded 5x-10x over the past week. The mechanism is that shorts facing an impossible borrow will be forced to cover into thin liquidity, driving rapid upside. The author discloses owning 4,500 shares at $9.80 and points to r/shortsqueeze for corroborating data. No specific risk is stated beyond the implicit squeeze dependency.

Author argues LFVN's $9 support was successfully defended and the stock is printing higher highs and higher lows, which he sees as the setup for a bigger move. His catalyst is breaking through $11 next week and turning $10 into support, after which he expects shorts to be squeezed. He states he would get concerned if $9 support is lost and the stock starts making lower lows toward $8.50 and below.

The author argues LifeVantage is a profitable, debt-free, dividend-paying supplement company with $195M revenue and 78% gross margins trading at a $100M market cap, making it a fundamentally sound squeeze candidate. The mechanism is a short squeeze: 36% of float sold short, 263% annualized borrow cost, zero shares available to borrow, and 3.59M shares needing to cover into a float with only 2-3M shares available, compounded by a $60M buyback. The catalyst is continued short covering after shorts failed to break $8 by dumping 2.54M shares, with the author's stated risk being that the squeeze fails and the stock falls to $6 fair value. The author holds shares, not options, citing expensive options and uncertain timeline.

The author argues LFVN's fundamentals are unchanged despite a 2% drop, and that high short interest and cost-to-borrow remain intact. They view the sideways action as base-building and shakeout typical of a squeeze rather than a breakdown through support. They expect the move to end in the $16-20 range, which they say would still be a great win for their calls, and they are still holding. Main risk acknowledged is that squeezes don't go straight up and the outcome is uncertain. Reported returns track the underlying asset, not option P&L.

aporter0131 claims LFVN is set for a major short squeeze because short interest, cost-to-borrow, days-to-cover and volume conditions will be reinforced by SEC Rule 201 tomorrow. The mechanism is that after a 10% intraday drop Rule 201 forces short sales above the National Best Bid, removing aggressive bid-slamming, creating a possible floor, and accelerating short covering. The stated catalyst is the Rule 201 restriction taking effect tomorrow and the author expects a big day of green. No explicit risk is stated.

The author argues LFVN is in a rare short squeeze where the stars align: short interest over 40%, days to cover at least 5, cost to borrow over 250%, and no shares left to short, with shorts established around $5 while the stock is just under $9. He views today's shakeout as a great entry point and says he holds a fairly large position. Main risk not explicitly stated beyond the shakeout itself.

The author has been long LFVN since before earnings and argues a short squeeze has started, with $9.25 being a major break marking the beginning of a forced buying period of around five days at current volume. He identifies resistance at $10, $12.50, and the 52-week high near $15, planning to take 25% profit at $14.50 and ride the rest; if $15 breaks, he expects $22-30. Main risk is emotional volatility from bouncing between resistance walls, which he warns against reacting to.

The author claims LFVN has a far more extreme short-squeeze setup than SPCE, citing 40% short interest, 5.7 days to cover, only 100 short shares available, and a 265% short borrow fee rate versus SPCE's 24% short interest, 0.34 days to cover, and 6.88% borrow fee. The mechanism is that scarce borrow and heavy short positioning force shorts to cover, driving a squeeze. The author is positioned via $10 July 17th calls, making the July expiry the catalyst window. Main risk implied is that the squeeze thesis depends on the cited short-interest data holding up. Reported returns track the underlying asset, not option P&L.

The author claims LFVN is shorted at roughly 3.85 million shares, about 39%-44% of a tiny float, with days-to-cover around 15 and borrow fees above 100%, so shorts face heavy carry costs. The stated catalyst is the June 1 dividend: shorts must pay dividends on borrowed shares, and any rise in buying volume plus short exits could force a chain reaction upward in an illiquid low-float name. Fundamentals are cited as supportive rather than distressed (profitable quarters, no debt, cash, raised dividend, ~$59 million buyback authorization), with possible guidance/operational improvement from leadership changes and restructuring later this year. Stated risk is implicit in the squeeze framing that it depends on volume actually flooding in; no price target is given.

The author holds a $30k long position in LFVN, arguing that short interest of 35-44%, a float of only 10 million shares, a cost to borrow over 77%, and 26 days to cover create a classic short-squeeze setup. The catalyst is any meaningful volume, which the author expects to send the stock 'on a rocket.' The author notes the company is authorized to buy back $60m in shares and has no debt, suggesting the short interest is unwarranted, while admitting he knows little about the business itself.